Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
185022-12-2
54149-41-6
93460-33-4
2183440-36-8 | APN-C3-PEG4-alkyne | AA019EEV
693793-71-4 | 2-(4-Fluorobenzylidene)-4-methyl-3-oxo-n-phenylpentanamide | AA019EIM | MFCD30472124
121006-52-8 | tert-butyl (2,5-dimethoxyphenyl)carbamate | AA019ELU | MFCD07127716
1988004-17-6 | N-(2-chloro-4-iodophenyl)-4-methyl-benzenesulfonamide | AA019EOI | MFCD31652795
1889959-79-8 | (2-cyclopropyloxazol-5-yl)methanol | AA019ERQ | MFCD30486448
35227-79-3 | 3,5-Diacetylanisol | AA019EVJ | MFCD22544430
226924-21-6 | 2-((tert-butoxycarbonyl)amino)-3-(2-cyanophenyl)propanoic acid | AA019EYB | MFCD09756564
97519-39-6 | Ceftibuten | AA019FRT | MFCD00864918
565456-74-8 | Ethyl 2-amino-3-cyclobutylpropanoate hcl | AA019G78 | MFCD17926291
406928-28-7 | 5-[(4-methoxyphenyl)sulfamoyl]-2-methylbenzoic acid | AA019GIK | MFCD02712079
